The global animal vaccine market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2021-2027). The market growth is mainly attributed to the introduction of new animal vaccines and approval of the animal vaccine by the key market players, such as Boehringer Ingelheim, Elanco, Merck, and Zoetis Inc. For instance, in January 2019, Boehringer Ingelheim initiated the supply of its swine vaccine Ingelvac PRRS MLV produced in China. Along with the introduction of new vaccines, the market players are donating the vaccine dosage in underdeveloped economies, where it cannot be afforded by the public. In September 2019, Boehringer Ingelheim pledged to donate 60,000 IMRAB rabies vaccines for dogs in the next three years in Puerto Rico. Earlier this, the company has donated 75,000 doses of the rabies vaccine to the Global Alliance for Rabies Control (GARC) in recognition of World Rabies Day in September 2018.
To Request a Sample of our Report on Animal Vaccine Market: https://www.omrglobal.com/request-sample/animal-vaccine-market
Similarly, in September 2019, Merck Animal Health donated three million vaccine dosages for rabies in different countries in Africa and India. Besides, In January 2020, Merck Animal Health and Automazioni VX, Inc. formed a collaboration agreement. The goal of this collaboration was to introduce Innoject Pro, a new subcutaneous chick vaccination method. The technology has been used in conjunction with Merck Animal Health’s Innovax vaccinations, which are designed to protect chickens from infectious diseases. In addition, factory farming is considered one of the major factors that contribute significantly to the growth of the global animal vaccine market. In factory farming, a large number of animals including cows, pigs, turkeys, goats, sheep, pigs, or chickens are held to increase the production of eggs, meat, beef, and milk at the lowest possible cost. In the US, more than 95% of animals are produced in factory farming for maximizing agribusiness profit.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Type
· By Technology
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
· Competitive Landscape- Boehringer Ingelheim International GmbH, Ceva Santé Animale, Virbac S.A., Zoetis Inc., and Merck & Co., Inc., among others
Key questions addressed by the report
· What is the market growth rate?
· Which segment and region dominate the market in the base year?
· Which segment and region will project the fastest growth in the market?
· How COVID-19 impacted the market?
· Deviation from the pre-COVID-19 forecast
· Most affected region and segment
· Who is the leader in the market?
· How players are addressing challenges to sustain growth?
· Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A full Report of Animal Vaccine Market is Available at: https://www.omrglobal.com/industry-reports/animal-vaccine-market
Global Animal Vaccine Market Report Segment
By Type
· Porcine Vaccines
· Poultry Vaccines
· Livestock Vaccines
· Aquaculture Vaccines
· Companion Animal Vaccines
· Other Animal Vaccines
By Technology
· Live Attenuated Vaccines
· Killed/Inactivated Vaccine
· Recombinant Vaccines
· Other
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
